Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 28% ± 13% | |
macrophage | 19 studies | 31% ± 13% | |
fibroblast | 14 studies | 26% ± 9% | |
astrocyte | 13 studies | 31% ± 13% | |
oligodendrocyte precursor cell | 11 studies | 32% ± 16% | |
microglial cell | 11 studies | 56% ± 17% | |
monocyte | 9 studies | 26% ± 7% | |
pericyte | 9 studies | 26% ± 10% | |
epithelial cell | 9 studies | 36% ± 21% | |
mast cell | 8 studies | 24% ± 5% | |
classical monocyte | 8 studies | 23% ± 9% | |
adipocyte | 8 studies | 46% ± 16% | |
dendritic cell | 7 studies | 25% ± 12% | |
endothelial cell of lymphatic vessel | 7 studies | 27% ± 6% | |
glutamatergic neuron | 7 studies | 47% ± 23% | |
hematopoietic stem cell | 7 studies | 39% ± 18% | |
myeloid cell | 7 studies | 29% ± 8% | |
retinal rod cell | 7 studies | 23% ± 6% | |
oligodendrocyte | 7 studies | 24% ± 9% | |
GABAergic neuron | 6 studies | 43% ± 18% | |
interneuron | 6 studies | 38% ± 17% | |
basal cell | 6 studies | 26% ± 9% | |
retinal cone cell | 6 studies | 31% ± 9% | |
Mueller cell | 6 studies | 28% ± 10% | |
non-classical monocyte | 5 studies | 28% ± 14% | |
secretory cell | 5 studies | 21% ± 7% | |
alveolar macrophage | 5 studies | 29% ± 10% | |
hematopoietic precursor cell | 4 studies | 43% ± 25% | |
pro-B cell | 4 studies | 38% ± 8% | |
club cell | 4 studies | 20% ± 3% | |
retinal pigment epithelial cell | 4 studies | 44% ± 3% | |
lymphocyte | 4 studies | 18% ± 4% | |
goblet cell | 4 studies | 24% ± 13% | |
conventional dendritic cell | 3 studies | 28% ± 7% | |
podocyte | 3 studies | 29% ± 14% | |
GABAergic interneuron | 3 studies | 33% ± 13% | |
granule cell | 3 studies | 29% ± 13% | |
neuron | 3 studies | 32% ± 13% | |
extravillous trophoblast | 3 studies | 59% ± 28% | |
retinal ganglion cell | 3 studies | 29% ± 5% | |
GABAergic amacrine cell | 3 studies | 31% ± 10% | |
ON-bipolar cell | 3 studies | 24% ± 7% | |
innate lymphoid cell | 3 studies | 19% ± 0% | |
vein endothelial cell | 3 studies | 22% ± 5% | |
hepatocyte | 3 studies | 61% ± 32% | |
endothelial cell of vascular tree | 3 studies | 24% ± 7% | |
connective tissue cell | 3 studies | 24% ± 3% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 53% ± 20% | |
enteroendocrine cell | 3 studies | 18% ± 1% | |
intestinal crypt stem cell | 3 studies | 20% ± 3% | |
group 3 innate lymphoid cell | 3 studies | 28% ± 11% | |
transit amplifying cell | 3 studies | 23% ± 7% | |
smooth muscle cell | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 37% ± 18% | |
lung | 7 studies | 20% ± 5% | |
eye | 7 studies | 25% ± 8% | |
peripheral blood | 4 studies | 25% ± 11% | |
placenta | 3 studies | 38% ± 16% | |
uterus | 3 studies | 26% ± 9% | |
liver | 3 studies | 29% ± 17% | |
intestine | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1696.06 | 1443 / 1445 | 98% | 31.48 | 180 / 183 |
breast | 100% | 3703.79 | 459 / 459 | 95% | 51.63 | 1062 / 1118 |
lung | 99% | 1691.97 | 575 / 578 | 95% | 20.99 | 1099 / 1155 |
prostate | 100% | 1717.17 | 245 / 245 | 94% | 26.33 | 470 / 502 |
pancreas | 99% | 1640.33 | 326 / 328 | 93% | 17.61 | 166 / 178 |
stomach | 99% | 1168.21 | 355 / 359 | 93% | 16.24 | 266 / 286 |
intestine | 100% | 2422.98 | 966 / 966 | 92% | 15.19 | 483 / 527 |
bladder | 100% | 1917.14 | 21 / 21 | 89% | 18.55 | 448 / 504 |
kidney | 100% | 1413.47 | 89 / 89 | 87% | 21.37 | 788 / 901 |
thymus | 100% | 1241.92 | 651 / 653 | 84% | 22.38 | 509 / 605 |
uterus | 100% | 2290.49 | 170 / 170 | 83% | 16.50 | 379 / 459 |
brain | 87% | 929.91 | 2307 / 2642 | 94% | 14.57 | 666 / 705 |
ovary | 100% | 2041.32 | 180 / 180 | 79% | 13.13 | 341 / 430 |
skin | 100% | 1806.84 | 1800 / 1809 | 79% | 15.72 | 374 / 472 |
liver | 100% | 1504.07 | 226 / 226 | 62% | 7.14 | 251 / 406 |
adrenal gland | 100% | 2528.88 | 258 / 258 | 48% | 5.20 | 111 / 230 |
adipose | 100% | 3846.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 4265.98 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1543.88 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.58 | 1 / 1 |
blood vessel | 99% | 1379.31 | 1327 / 1335 | 0% | 0 | 0 / 0 |
heart | 90% | 907.84 | 771 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 16.56 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 48% | 4.04 | 14 / 29 |
eye | 0% | 0 | 0 / 0 | 41% | 3.62 | 33 / 80 |
peripheral blood | 40% | 395.50 | 369 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0007623 | Biological process | circadian rhythm |
GO_0019915 | Biological process | lipid storage |
GO_0001543 | Biological process | ovarian follicle rupture |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | NRIP1 |
Protein name | Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140) Nuclear receptor interacting protein 1 |
Synonyms | |
Description | FUNCTION: Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors. Positive regulator of the circadian clock gene expression: stimulates transcription of BMAL1, CLOCK and CRY1 by acting as a coactivator for RORA and RORC. Involved in the regulation of ovarian function (By similarity). Plays a role in renal development . . |
Accessions | ENST00000400202.5 ENST00000638122.1 P48552 ENST00000318948.7 C9J130 ENST00000411932.1 ENST00000400199.5 A0A1B0GUG9 |